OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00063555

Ningxia Younglight Chemicals Co Ltd

Commodity ChemicalsVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.54, indicating a moderate reliance on debt financing. However, its liquidity position is weak, as evidenced by a current ratio of 0.32, which is significantly below the industry median. The company reported negative operating and free cash flows of -453.5 million CNY and -467.3 million CNY, respectively, raising concerns about its ability to fund operations without external financing. Profitability metrics are deeply negative, with a return on equity of -45.14% and a return on assets of -22.3%. These figures are far below the industry median for commodity chemicals, which typically report positive returns in stable market conditions. The company's gross profit was -341.2 million CNY, and its operating income was -578.9 million CNY, indicating a severe margin compression likely driven by high input costs or weak pricing power. The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no material geographic diversification beyond China. This lack of diversification increases exposure to domestic economic and regulatory risks, particularly in the chemicals sector, which is subject to environmental and safety regulations. The company's growth trajectory is negative, with a reported revenue of 1.71 billion CNY in the latest period. While historical revenue data is not provided, the current financial performance suggests a contraction in operations. The outlook for the current fiscal year is not explicitly provided, but the negative operating and free cash flows indicate a challenging operating environment. The company's risk profile is elevated, with a medium liquidity risk and a low dilution risk. The negative net cash position, after subtracting total debt, suggests a potential need for additional financing, which could lead to increased leverage or equity dilution. However, the dilution risk is currently assessed as low, with no immediate signs of share issuance or capital raising. Recent events include a significant decline in profitability, as reflected in the negative net income of -553.6 million CNY. The company has also reported a capital expenditure of -82.8 million CNY, indicating a reduction in investment in new projects or capacity expansion. No recent filings or transcripts are provided to explain the operational or strategic changes.

30-day price · 000635-0.53 (-6.2%)
Low$7.85High$8.88Close$8.02As of15 May, 00:00 UTC
Profile
CompanyNingxia Younglight Chemicals Co Ltd
Ticker000635.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Ningxia Younglight Chemicals Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily serving domestic and international industrial markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

The company's capital structure is characterized by a debt-to-equity ratio of 0.54, indicating a moderate reliance on debt financing. However, its liquidity position is weak, as evidenced by a current ratio of 0.32, which is significantly below the industry median. The company reported negative operating and free cash flows of -453.5 million CNY and -467.3 million CNY, respectively, raising concerns about its ability to fund operations without external financing. Profitability metrics are deeply negative, with a return on equity of -45.14% and a return on assets of -22.3%. These figures are far below the industry median for commodity chemicals, which typically report positive returns in stable market conditions. The company's gross profit was -341.2 million CNY, and its operating income was -578.9 million CNY, indicating a severe margin compression likely driven by high input costs or weak pricing power. The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no material geographic diversification beyond China. This lack of diversification increases exposure to domestic economic and regulatory risks, particularly in the chemicals sector, which is subject to environmental and safety regulations. The company's growth trajectory is negative, with a reported revenue of 1.71 billion CNY in the latest period. While historical revenue data is not provided, the current financial performance suggests a contraction in operations. The outlook for the current fiscal year is not explicitly provided, but the negative operating and free cash flows indicate a challenging operating environment. The company's risk profile is elevated, with a medium liquidity risk and a low dilution risk. The negative net cash position, after subtracting total debt, suggests a potential need for additional financing, which could lead to increased leverage or equity dilution. However, the dilution risk is currently assessed as low, with no immediate signs of share issuance or capital raising. Recent events include a significant decline in profitability, as reflected in the negative net income of -553.6 million CNY. The company has also reported a capital expenditure of -82.8 million CNY, indicating a reduction in investment in new projects or capacity expansion. No recent filings or transcripts are provided to explain the operational or strategic changes.
Key takeaways
  • The company is experiencing severe margin compression and negative profitability, with a return on equity of -45.14%.
  • Liquidity is a critical concern, with a current ratio of 0.32 and negative operating and free cash flows.
  • The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.54.
  • Revenue is concentrated in a single business segment, increasing exposure to domestic market risks.
  • The company's growth trajectory is negative, with no clear signs of improvement in the near term.
  • The risk of dilution is currently low, but the negative net cash position may necessitate future financing.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.71B
Gross profit-$341.2M
Operating income-$578.9M
Net income-$553.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$453.5M
CapEx-$82.8M
Free cash flow-$467.3M
Total assets$2.48B
Total liabilities$1.26B
Total equity$1.23B
Cash & equivalents
Long-term debt$663.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.71B-$578.7M-$553.6M-$467.3M
FY-1$1.85B-$501.7M-$502.6M-$385.8M
FY-2$1.75B-$594.3M-$667.8M-$631.2M
FY-3$1.88B-$467.0M-$388.9M-$289.6M
FY-4$2.29B$12.0M$4.3M$65.8M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$2.48B$1.23B
FY-1$2.57B$1.10B
FY-2$2.68B$1.60B
FY-3$2.73B$2.27B
FY-4$3.06B$2.66B
PeriodOCFCapExFCFSBC
FY0-$453.5M-$82.8M-$467.3M
FY-1-$493.8M-$37.8M-$385.8M
FY-2-$596.4M-$77.9M-$631.2M
FY-3-$161.6M-$18.9M-$289.6M
FY-4$147.4M-$12.9M$65.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$382.8M-$129.1M-$129.1M
FQ-1$429.6M-$334.4M-$306.1M
FQ-2$413.1M-$93.4M-$91.8M
FQ-3$466.9M-$66.6M-$73.3M
FQ-4$400.1M-$84.3M-$82.2M
FQ-5$470.1M-$248.9M-$244.6M
FQ-6$412.7M-$131.1M-$134.4M
FQ-7$553.6M-$48.4M-$53.7M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$2.45B$1.10B$95.0M
FQ-1$2.48B$1.23B
FQ-2$2.99B$1.54B$450.8M
FQ-3$2.64B$953.3M
FQ-4$2.66B$1.02B$8.4M
FQ-5$2.57B$1.10B
FQ-6$2.65B$1.35B$31.4M
FQ-7$2.80B$1.48B
PeriodOCFCapExFCFSBC
FQ0-$110.2M-$28.6M
FQ-1-$453.5M-$82.8M
FQ-2-$305.6M-$69.4M
FQ-3-$318.3M-$23.2M
FQ-4-$264.0M-$3.0M
FQ-5-$493.8M-$37.8M
FQ-6-$414.2M-$12.0M
FQ-7-$383.9M-$9.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.23B
Net cash-$663.8M
Current ratio0.3
Debt/Equity0.5
ROA-22.3%
ROE-45.1%
Cash conversion82.0%
CapEx/Revenue-4.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric000635Activity
Op margin-33.9%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-32.4%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin-20.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity54.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 03:03 UTCJob: d5346fe3